Safety and efficacy of skin care formulatio
- Registration Number
- CTRI/2022/01/039134
- Lead Sponsor
- Kama Ayurveda Pvt Ltd
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Having moderate to severe hair fall.
Having Moderate to severe dandruff where 0 is None, 1 is Slight, 2 is Mild, 3 is Moderate, 4
is Severe
Suffering with hair thinning on subject assessment basis.
For female: Having at least shoulder length hair.
Having washed their hair with provided neutral shampoo, 48 hours before the first day of the
study with the provided nuetral shampoo.
Having untangled their hair at home, 3 hours prior coming to the site for observations, the first
day of the study.
Small, red bumps on the scalp, neck, and shoulders (bumps may become crusty and ooze)
Subject having applied a product with an anti-hair fall claim (due to breakage)or anti dandruff claim in the 2 weeks preceding the start of the study
Having surgery history on the scalp (micro transplants â?¦)
In the previous 6 months
- Having undergone the Minoxidil treatments
- Antiandrogen medicine (cyproterone acetate, spironolactone, flutamide)
- Having undergone one of the following treatments known to : induce hair loss : retinoids, anti coagulants, anti-convulsive drugs, chemotherapy, beta-blocking agents, non steroidal anti inflammatory drugs, corticoids â?¦
- Having modified her hormonal contraception
In the previous 3 months
- Having undergone a local or general anti hair loss treatment (Biotine, dexpanthenol, sulphur amino-acid, B6 vitamin, zinc â?¦)
- Having taken a food supplement with an anti hair loss claim
- Having taken an iron based treatment
In the previous 15 days
- Having applied a product with an anti hair loss claim (due to breakage) or anti dandruff claim
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method efficacy of hair care formulation in <br/ ><br>terms of reduction in Hair Fall and Anti-dandruff effectTimepoint: T0, T14 days and T28 days
- Secondary Outcome Measures
Name Time Method SafetyTimepoint: T0, T14 days and T28 days